References

References:

  1. Flanagan AM, Tirabosco R, O’Donnell PG, Yamaguchi T. Conventional chordoma. In: WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2024 Jul 10]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/chapters/33.
  2. Frezza AM, Botta L, Trama A, Dei Tos AP, Stacchiotti S. Chordoma: update on disease, epidemiology, biology and medical therapies. Curr Opin Oncol. 2019;31(2):114-120. doi:10.1097/CCO.0000000000000502
  3. Kelley MJ, Shi J, Ballew B, et al. Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma. Hum Genet. 2014;133(10):1289-1297. doi:10.1007/s00439-014-1463-z
  4. Lee‐Jones L, Aligianis I, Davies PA, et al. Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2. Genes Chromosomes Cancer. 2004;41(1):80-85. doi:10.1002/gcc.20052
  5. Tarpey PS, Behjati S, Young MD, et al. The driver landscape of sporadic chordoma. Nat Commun. 2017;8(1):890. doi:10.1038/s41467-017-01026-0
  6. Fernandez-Miranda JC, Gardner PA, Snyderman CH, et al. Clival chordomas: A pathological, surgical, and radiotherapeutic review. Head Neck. 2014;36(6):892-906. doi:10.1002/HED.23415
  7. Wu Z, Zhang J, Zhang L, et al. Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas-106 cases review in one institution. Neurosurg Rev. 2010;33(4):451-456. doi:10.1007/S10143-010-0273-6
  8. Ulici V, Hart J. Chordoma. Arch Pathol Lab Med. 2022;146(3):386-395. doi:10.5858/arpa.2020-0258-RA
  9. Carter JM, Wenger DE, Rose PS, Inwards CY. Atypical Notochordal Cell Tumors. American Journal of Surgical Pathology. 2017;41(1):39-48. doi:10.1097/PAS.0000000000000766
  10. Wasserman JK, Gravel D, Purgina B. Chordoma of the Head and Neck: A Review. Head Neck Pathol. 2018;12(2):261-268. doi:10.1007/S12105-017-0860-8